A longevity startup has dosed its first patient with a drug to reverse age-related sight loss.
Life Biosciences is testing its ER-100 drug, which has been Read Entire Article
- Homepage
- Technology
- Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss
Related
Those Viral Bodega Peptides Aren’t Actually Peptides
21 hours ago
9
AI Agents Are Thirsty for Power
2 days ago
19
RIGHT SIDEBAR TOP AD
Popular
RIGHT SIDEBAR BOTTOM AD
About Us ·
Contact Us ·
Terms & Conditions ·
Privacy Policy ·
DMCA ·
Cookie Policy ·
Advertise With Us ·
© Primetweets 2026. All rights are reserved

3 months ago
96

.jpg?mbid=social_retweet)






English (US) ·